Clinical and Experimental Reproductive Medicine

The Korean Society for Reproductive Medicine (대한생식의학회)
권호 표지
DOI QR코드

DOI QR Code

Uterine infarction in a patient with uterine adenomyosis following biochemical pregnancy

  • Lee, Jae-Yeon (Department of Obstetrics and Gynecology, SMG-SNU Boramae Medical Center) ;
  • Hwang, Kyu-Ri (Department of Obstetrics and Gynecology, SMG-SNU Boramae Medical Center) ;
  • Won, Kyu-Hee (Department of Obstetrics and Gynecology, SMG-SNU Boramae Medical Center) ;
  • Lee, Da-Yong (Department of Obstetrics and Gynecology, SMG-SNU Boramae Medical Center) ;
  • Jeon, Hye-Won (Department of Obstetrics and Gynecology, SMG-SNU Boramae Medical Center) ;
  • Moon, Min-Hwan (Department of Radiology, SMG-SNU Boramae Medical Center)
  • Received : 2014.06.13
  • Accepted : 2014.11.14
  • Published : 2014.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Adenomyosis is a common gynecological disorder characterized by the presence of endometrial glands and stroma deep within the myometrium associated with myometrial hypertrophy and hyperplasia. Focal uterine infarction after IVF-ET in a patient with adenomyosis following biochemical pregnancy has not been previously reported, although it occurs after uterine artery embolization in order to control symptoms caused by fibroids or adenomyosis. We report a case of a nulliparous woman who had uterine adenomyosis presenting with fever, pelvic pain and biochemical abortion after undergoing an IVF-ET procedure and the detection of a slightly elevated serum hCG. Focal uterine infarction was suspected after a pelvic magnetic resonance imaging demonstrated preserved myometrium between the endometrial cavity and inner margin of the necrotic myometrium. This case demonstrates that focal uterine infarction should be considered in the differential diagnosis of acute abdominal pain, vaginal bleeding and infectious signs in women experiencing biochemical abortion after an IVF-ET procedure.

Keywords

References

  1. Valentini AL, Speca S, Gui B, Soglia G, Micco M, Bonomo L. Adenomyosis: from the sign to the diagnosis. Imaging, diagnostic pitfalls and differential diagnosis: a pictorial review. Radiol Med 2011;116:1267-87. https://doi.org/10.1007/s11547-011-0714-5
  2. Devlieger R, D'Hooghe T, Timmerman D. Uterine adenomyosis in the infertility clinic. Hum Reprod Update 2003;9:139-47. https://doi.org/10.1093/humupd/dmg010
  3. Bradley LD. Uterine fibroid embolization: a viable alternative to hysterectomy. Am J Obstet Gynecol 2009;201:127-35. https://doi.org/10.1016/j.ajog.2009.01.031
  4. Kim MD, Kim S, Kim NK, Lee MH, Ahn EH, Kim HJ, et al. Long-term results of uterine artery embolization for symptomatic adenomyosis. AJR Am J Roentgenol 2007;188:176-81. https://doi.org/10.2214/AJR.05.1613
  5. Nijenhuis RJ, Smeets AJ, Morpurgo M, Boekkooi PF, Reuwer PJ, Smink M, et al. Uterine artery embolisation for symptomatic adenomyosis with polyzene f-coated hydrogel microspheres: threeyear clinical follow-up using UFS-QoL Questionnaire. Cardiovasc Intervent Radiol 2014 Apr 2 [Epub]. http:// doi.dx.org.10.1007/s00270-014-0878-1.
  6. Bergholt T, Eriksen L, Berendt N, Jacobsen M, Hertz JB. Prevalence and risk factors of adenomyosis at hysterectomy. Hum Reprod 2001;16:2418-21. https://doi.org/10.1093/humrep/16.11.2418
  7. Verma SK, Gonsalves CF, Baltarowich OH, Mitchell DG, Lev-Toaff AS, Bergin D. Spectrum of imaging findings on MRI and CT after uterine artery embolization. Abdom Imaging 2010;35:118-28. https://doi.org/10.1007/s00261-008-9483-6
  8. Lohle PN, De Vries J, Klazen CA, Boekkooi PF, Vervest HA, Smeets AJ, et al. Uterine artery embolization for symptomatic adenomyosis with or without uterine leiomyomas with the use of calibrated tris-acryl gelatin microspheres: midterm clinical and MR imaging follow-up. J Vasc Interv Radiol 2007;18:835-41. https://doi.org/10.1016/j.jvir.2007.04.024
  9. Levin I, Gamzu R, Pauzner D, Rogowski O, Shapira I, Maslovitz S, et al. Elevated levels of CRP in ovarian hyperstimulation syndrome: an unrecognised potential hazard? BJOG 2005;112:952-5. https://doi.org/10.1111/j.1471-0528.2005.00602.x
  10. Brenner B. Thrombophilia in pregnancy and its role in abortion. Womens Health (Lond Engl) 2005;1:35-8. https://doi.org/10.2217/17455057.1.1.35
  11. Alatri A, Tribout B, Gencer B, Calanca L, Mazzolai L. Thrombotic risk in assisted reproductive technology. Rev Med Suisse 2011;7:357-60.
  12. Hansen AT, Kesmodel US, Juul S, Hvas AM. Increased venous thrombosis incidence in pregnancies after in vitro fertilization. Hum Reprod 2014;29:611-7. https://doi.org/10.1093/humrep/det458
  13. Targher G, Pichiri I, Zoppini G, Bonora E, Chonchol M. Hemostatic and fibrinolytic abnormalities in endocrine diseases: a narrative review. Semin Thromb Hemost 2009;35:605-12. https://doi.org/10.1055/s-0029-1242714
  14. Sabatini L, Atiomo W, Magos A. Successful myomectomy following infected ischaemic necrosis of uterine fibroids after uterine artery embolisation. BJOG 2003;110:704-6. https://doi.org/10.1046/j.1471-0528.2003.02105.x
  15. Perri T, Korach J, Sadetzki S, Oberman B, Fridman E, Ben-Baruch G. Uterine leiomyosarcoma: does the primary surgical procedure matter? Int J Gynecol Cancer 2009;19:257-60. https://doi.org/10.1111/IGC.0b013e31819a1f8f
  16. D'Angelo E, Prat J. Uterine sarcomas: a review. Gynecol Oncol 2010;116:131-9. https://doi.org/10.1016/j.ygyno.2009.09.023

Cited by

  1. LPS/TLR4-mediated stromal cells acquire an invasive phenotype and are implicated in the pathogenesis of adenomyosis vol.6, pp.None, 2014, https://doi.org/10.1038/srep21416
  2. Successful conservative treatment for massive uterine bleeding with non-septic disseminated intravascular coagulation after termination of early pregnancy in a woman with huge adenomyosis: case report vol.20, pp.1, 2014, https://doi.org/10.1186/s12905-020-00924-8